Welcome
The aim of this website is to provide Belgian oncologists with swift access to clinical trial opportunities for their patients, with the possibility to directly contact one of the sites where the trial is open.
This search portal combines a structured national database with intuitive filters by disease, centre, molecule and report extraction to help clinicians identify relevant trials efficiently.
The methodology relies on curated Belgian trial data and a practical search interface designed to make navigation clear, fast and clinically useful.
Main scientific and medical input: Dr. Cédric van Marcke, Dr Joëlle Collignon and Dr Hans Prenen, as well as several other oncologists.
Search the Belgian trial database
An extensive Belgian trial database with a dedicated search engine helps doctors identify clinical trials that may be suitable for their patients, including studies of innovative treatments and genotype-driven trials. Five complementary search routes bring the information together in one clinical workflow.
One database, five clinical entry points
Discover five complementary ways to identify relevant Belgian oncology trials. Start from the patient’s disease, a recruiting centre, a drug or molecule, a clinical report, or a dictated clinical summary.
By disease
Start from an organ or cancer type, then refine by subtype, treatment setting and optional biomarkers. Results are drawn from the Belgian trial database and keep the search focused on the patient’s clinical context.
By centre
Explore which trials are available at each Belgian recruiting centre. This view is especially useful when location or referral options matter and helps clinicians identify where a relevant study is open.
By drug / molecule
Browse studies by therapeutic family, molecule or drug name. This view helps clinicians follow a specific treatment strategy across indications and see where that agent is being investigated in Belgium.
Beta versionUpload a report
Upload or paste a clinical report and let the system extract disease terms, alternative diagnoses and biomarkers. The extracted information can be reviewed and validated before it is used to retrieve matching trials.
Voice search
Dictate a short clinical summary instead of typing it. The system converts speech into disease and biomarker terms, proposes alternatives when recognition is uncertain, and uses the validated information to search for matching trials.
Beta versionWhat are Clinical Trials?
Clinical trials are a key step in the development and evaluation of new treatments.
Before a new treatment reaches routine care, it is studied through carefully designed research. Patients who participate receive information about the study, its possible benefits, its risks and the alternatives before giving informed consent.
Phases in clinical trials
Early studies focus mainly on safety, dosage and initial signs of activity.
A larger group is studied to better assess efficacy and adverse events.
The new approach is compared with existing standards in a larger patient population.
Post-marketing studies can evaluate longer-term outcomes and rarer adverse events.
Should I participate in a clinical trial?
Participation is a personal medical decision that should be discussed with the treating team. A trial may offer access to a promising treatment and close follow-up, but it may also involve uncertainty, extra visits, tests or unexpected side effects.
Potential benefits
- Early access to a promising treatment.
- Structured follow-up within a research programme.
- Contribution to better future cancer care.
Potential risks
- The new treatment may not work better than standard care.
- Unexpected adverse events can occur.
- Participation can require extra procedures or visits.
Informed consent
Before joining a study, patients receive information about the trial, potential benefits, risks and alternatives. Participation remains voluntary and consent can be withdrawn.
How to submit or update a trial?
Professionals may request the addition or update of a trial running in Belgium. Recruitment status, site details, investigator information and approved supporting material should be kept current.
For trial updates or missing studies, contact info@clinicaltrial.be.